Protein adsorption determines pulmonary cell uptake of lipid-based nanoparticles.


Journal

Journal of colloid and interface science
ISSN: 1095-7103
Titre abrégé: J Colloid Interface Sci
Pays: United States
ID NLM: 0043125

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 16 01 2023
revised: 05 03 2023
accepted: 07 03 2023
medline: 11 4 2023
pubmed: 17 3 2023
entrez: 16 3 2023
Statut: ppublish

Résumé

The inhalable administration of lipid nanoparticles is an effective strategy for localised delivery of therapeutics against various lung diseases. Of this, improved intracellular delivery of pharmaceuticals for infectious disease and cancer management is of high significance. However, the influence of lipid nanoparticle composition and structure on uptake in pulmonary cell lines, especially in the presence of biologically relevant media is poorly understood. Here, the uptake of lamellar (liposomes) versus non-lamellar (cubosomes) lipid nanoparticles in macrophages and lung epithelial cells was quantified and the influence of bronchoalveolar lavage fluid (BALF), containing native pulmonary protein and surfactant molecules is determined. Cubosome uptake in both macrophages and epithelial cells was strongly mediated by a high percentage of molecular function regulatory and binding proteins present within the protein corona. In contrast, the protein corona did not influence the uptake of liposomes in epithelial cells. In macrophages, the proteins mediated a rapid internalisation, followed by exocytosis of liposomes after 6 h incubation. These findings on the influence of biological fluid in regulating lipid nanoparticle uptake mechanisms may guide future development of optimal intracellular delivery systems for therapeutics via the pulmonary route.

Identifiants

pubmed: 36924544
pii: S0021-9797(23)00407-1
doi: 10.1016/j.jcis.2023.03.048
pii:
doi:

Substances chimiques

Lipid Nanoparticles 0
Liposomes 0
Protein Corona 0
Proteins 0
Lipids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-47

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Santhni Subramaniam (S)

University of South Australia, UniSA Clinical and Health Sciences, SA 5000, Australia.

Paul Joyce (P)

University of South Australia, UniSA Clinical and Health Sciences, SA 5000, Australia.

Leigh Donnellan (L)

University of South Australia, UniSA Clinical and Health Sciences, SA 5000, Australia.

Clifford Young (C)

University of South Australia, UniSA Clinical and Health Sciences, SA 5000, Australia.

Anthony Wignall (A)

University of South Australia, UniSA Clinical and Health Sciences, SA 5000, Australia.

Peter Hoffmann (P)

University of South Australia, UniSA Clinical and Health Sciences, SA 5000, Australia.

Clive A Prestidge (CA)

University of South Australia, UniSA Clinical and Health Sciences, SA 5000, Australia. Electronic address: Clive.Prestidge@unisa.edu.au.

Articles similaires

Databases, Protein Protein Domains Protein Folding Proteins Deep Learning
Respiratory Syncytial Virus Infections Humans Animals Mice STAT3 Transcription Factor
Animals Lung India Sheep Transcriptome
Tumor Microenvironment Nanoparticles Immunotherapy Cellular Senescence Animals

Classifications MeSH